Skip to content

FARMAPHAR: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

FARMAPHAR

BE 0607.999.166
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€96,414
2024 · €47,688+€48,726
Equity
€46,889
2024 · €121,889-€75,000
Cash
€286,471
2024 · €281,399+€5,072
Balance sheet total
€634,998
2024 · €909,307-€274,309

Largest movements

2024 to 2025
Assets
  • Current investments -€290,000

    no longer reported in 2025 (was €290,000)

  • Receivables within one year +€28,121

    up €28,121 (+47.9%), from €58,741 to €86,862

    of which Trade receivables: +€40,876

  • Deferred charges and accrued income -€10,853

    down €10,853 (-78.6%), from €13,817 to €2,963

  • Tangible fixed assets -€9,736

    down €9,736 (-6.0%), from €161,643 to €151,907

    of which Land and buildings: -€6,751

Equity and liabilities
  • Other debts -€203,493

    down €203,493 (-28.9%), from €704,211 to €500,718

  • Reserves -€75,000

    down €75,000 (-72.6%), from €103,289 to €28,289

  • Trade debts +€23,935

    up €23,935 (+54.8%), from €43,684 to €67,620

  • Accrued charges and deferred income -€23,576

    down €23,576 (-89.9%), from €26,230 to €2,654

Income statement
  • Gross operating margin +€68,812

    up €68,812 (+38.1%), from €180,624 to €249,436

  • Staff costs +€41,019

    up €41,019 (+65.8%), from €62,385 to €103,404

  • Financial charges -€33,686

    down €33,686 (-70.4%), from €47,847 to €14,161

  • Taxes +€15,569

    up €15,569 (+91.7%), from €16,983 to €32,552

  • Financial income +€3,480

    up €3,480 (+83.7%), from €4,156 to €7,636

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €47,688
Gross operating margin +€68,812
Staff costs -€41,019
Depreciation -€814
Other operating charges +€150
Financial income +€3,480
Financial charges +€33,686
Taxes -€15,569
Result 2025 €96,414
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€113,514
Investment +€290,000
Financing -€171,414
Cash 2024 €281,399
Net result for the year +€96,414
Depreciation +€9,736
Stocks and contracts -€3,088
Receivables within one year -€28,121
Deferred charges and accrued income +€10,853
Trade debts +€23,935
Tax, wage and social debts +€3,825
Other debts -€203,493
Accrued charges and deferred income -€23,576
Current investments +€290,000
Contributions, distributions and other -€171,414
Cash 2025 €286,471
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €909,307 €634,998 -€274,309 -30.2%
Fixed assets 21/28 €161,643 €151,907 -€9,736 -6.0%
Tangible fixed assets 22/27 €161,643 €151,907 -€9,736 -6.0%
Land and buildings 22 €153,247 €146,496 -€6,751 -4.4%
Plant, machinery and equipment 23 €2,098 €1,538 -€559 -26.7%
Furniture and vehicles 24 €3,821 €2,239 -€1,582 -41.4%
Other tangible fixed assets 26 €2,476 €1,633 -€843 -34.0%
Current assets 29/58 €747,665 €483,092 -€264,573 -35.4%
Stocks and contracts in progress 3 €103,708 €106,795 +€3,088 +3.0%
Stocks 30/36 €103,708 €106,795 +€3,088 +3.0%
Amounts receivable within one year 40/41 €58,741 €86,862 +€28,121 +47.9%
Trade receivables 40 €44,206 €85,081 +€40,876 +92.5%
Other amounts receivable 41 €14,535 €1,780 -€12,755 -87.8%
Current investments 50/53 €290,000 - -€290,000
Cash at bank and in hand 54/58 €281,399 €286,471 +€5,072 +1.8%
Deferred charges and accrued income 490/1 €13,817 €2,963 -€10,853 -78.6%
Total equity and liabilities 10/49 €909,307 €634,998 -€274,309 -30.2%
Equity 10/15 €121,889 €46,889 -€75,000 -61.5%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €103,289 €28,289 -€75,000 -72.6%
Distributable reserves 133 €103,289 €28,289 -€75,000 -72.6%
Amounts payable 17/49 €787,419 €588,110 -€199,309 -25.3%
Amounts payable within one year 42/48 €761,189 €585,456 -€175,733 -23.1%
Trade debts 44 €43,684 €67,620 +€23,935 +54.8%
Suppliers 440/4 €43,684 €67,620 +€23,935 +54.8%
Taxes, remuneration and social security 45 €13,293 €17,118 +€3,825 +28.8%
Taxes 450/3 €9,968 €4,642 -€5,325 -53.4%
Remuneration and social security 454/9 €3,326 €12,476 +€9,150 +275%
Other amounts payable 47/48 €704,211 €500,718 -€203,493 -28.9%
Accrued charges and deferred income 492/3 €26,230 €2,654 -€23,576 -89.9%
Remuneration, social security and pensions 62 €62,385 €103,404 +€41,019 +65.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,921 €9,736 +€814 +9.1%
Other operating charges 640/8 €956 €805 -€150 -15.7%
Gross operating margin 9900 €180,624 €249,436 +€68,812 +38.1%
Operating profit (loss) 9901 €108,362 €135,490 +€27,129 +25.0%
Financial income 75/76B €4,156 €7,636 +€3,480 +83.7%
Recurring financial income 75 €4,156 €7,636 +€3,480 +83.7%
Financial charges 65/66B €47,847 €14,161 -€33,686 -70.4%
Recurring financial charges 65 €47,847 €14,161 -€33,686 -70.4%
Profit (loss) for the period before taxes 9903 €64,671 €128,966 +€64,295 +99.4%
Income taxes 67/77 €16,983 €32,552 +€15,569 +91.7%
Profit (loss) for the period 9904 €47,688 €96,414 +€48,726 +102%
Profit (loss) for the period to be appropriated 9905 €47,688 €96,414 +€48,726 +102%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.